Forced expiration measurements in mouse models of obstructive and restrictive lung diseases.
Ontology highlight
ABSTRACT: Background
Pulmonary function measurements are important when studying respiratory disease models. Both resistance and compliance have been used to assess lung function in mice. Yet, it is not always clear how these parameters relate to forced expiration (FE)-related parameters, most commonly used in humans. We aimed to characterize FE measurements in four well-established mouse models of lung diseases.Method
Detailed respiratory mechanics and FE measurements were assessed concurrently in Balb/c mice, using the forced oscillation and negative pressure-driven forced expiration techniques, respectively. Measurements were performed at baseline and following increasing methacholine challenges in control Balb/c mice as well as in four disease models: bleomycin-induced fibrosis, elastase-induced emphysema, LPS-induced acute lung injury and house dust mite-induced asthma.Results
Respiratory mechanics parameters (airway resistance, tissue damping and tissue elastance) confirmed disease-specific phenotypes either at baseline or following methacholine challenge. Similarly, lung function defects could be detected in each disease model by at least one FE-related parameter (FEV0.1, FEF0.1, FVC, FEV0.1/FVC ratio and PEF) at baseline or during the methacholine provocation assay.Conclusions
FE-derived outcomes in four mouse disease models behaved similarly to changes found in human spirometry. Routine combined lung function assessments could increase the translational utility of mouse models.
PROVIDER: S-EPMC5477381 | BioStudies |
REPOSITORIES: biostudies
Similar Datasets
Project description:<h4>Objective</h4>Emphysema and small-airway disease are the two major components of chronic obstructive pulmonary disease (COPD). We propose a novel method of quantitative computed tomography (CT) emphysema air-trapping composite (EAtC) mapping to assess each COPD component. We analyzed the potential use of this method for assessing lung function in patients with COPD.<h4>Materials and methods</h4>A total of 584 patients with COPD underwent inspiration and expiration CTs. Using pairwise analysis of inspiration and expiration CTs with non-rigid registration, EAtC mapping classified lung parenchyma into three areas: Normal, functional air trapping (fAT), and emphysema (Emph). We defined fAT as the area with a density change of less than 60 Hounsfield units (HU) between inspiration and expiration CTs among areas with a density less than -856 HU on inspiration CT. The volume fraction of each area was compared with clinical parameters and pulmonary function tests (PFTs). The results were compared with those of parametric response mapping (PRM) analysis.<h4>Results</h4>The relative volumes of the EAtC classes differed according to the Global Initiative for Chronic Obstructive Lung Disease stages (<i>p</i> < 0.001). Each class showed moderate correlations with forced expiratory volume in 1 second (FEV<sub>1</sub>) and FEV<sub>1</sub>/forced vital capacity (FVC) (<i>r</i> = -0.659-0.674, <i>p</i> < 0.001). Both fAT and Emph were significant predictors of FEV<sub>1</sub> and FEV<sub>1</sub>/FVC (R² = 0.352 and 0.488, respectively; <i>p</i> < 0.001). fAT was a significant predictor of mean forced expiratory flow between 25% and 75% and residual volume/total vital capacity (R² = 0.264 and 0.233, respectively; <i>p</i> < 0.001), while Emph and age were significant predictors of carbon monoxide diffusing capacity (R² = 0.303; <i>p</i> < 0.001). fAT showed better correlations with PFTs than with small-airway disease on PRM.<h4>Conclusion</h4>The proposed quantitative CT EAtC mapping provides comprehensive lung functional information on each disease component of COPD, which may serve as an imaging biomarker of lung function.
| S-EPMC8484152 | BioStudies
Project description:<h4>Background</h4>We assessed the difference in lung motion during inspiration/expiration between chronic obstructive pulmonary disease (COPD) patients and healthy volunteers using vector-field dynamic x-ray (VF-DXR) with optical flow method (OFM).<h4>Methods</h4>We enrolled 36 COPD patients and 47 healthy volunteers, classified according to pulmonary function into: normal, COPD mild, and COPD severe. Contrast gradient was obtained from sequential dynamic x-ray (DXR) and converted to motion vector using OFM. VF-DXR images were created by projection of the vertical component of lung motion vectors onto DXR images. The maximum magnitude of lung motion vectors in tidal inspiration/expiration, forced inspiration/expiration were selected and defined as lung motion velocity (LMV). Correlations between LMV with demographics and pulmonary function and differences in LMV between COPD patients and healthy volunteers were investigated.<h4>Results</h4>Negative correlations were confirmed between LMV and % forced expiratory volume in one second (%FEV<sub>1</sub>) in the tidal inspiration in the right lung (Spearman's rank correlation coefficient, r<sub>s</sub> = -0.47, p < 0.001) and the left lung (r<sub>s</sub> = -0.32, p = 0.033). A positive correlation between LMV and %FEV<sub>1</sub> in the tidal expiration was observed only in the right lung (r<sub>s</sub> = 0.25, p = 0.024). LMVs among normal, COPD mild and COPD severe groups were different in the tidal respiration. COPD mild group showed a significantly larger magnitude of LMV compared with the normal group.<h4>Conclusions</h4>In the tidal inspiration, the lung parenchyma moved faster in COPD patients compared with healthy volunteers. VF-DXR was feasible for the assessment of lung parenchyma using LMV.
| S-EPMC8802288 | BioStudies
Project description:<h4>Background</h4>In patients with chronic obstructive pulmonary disease (COPD), the independent contributions of individual lung function variables to outcomes may be lower when they are modelled together if they are collinear. In addition, lung volume measurements may not be necessary after spirometry data have been obtained. However, these hypotheses depend on whether forced vital capacity (FVC) can predict total lung capacity (TLC). Moreover, the definitions of hyperinflation and air trapping according to lung function variables overlap and need be clarified. Therefore, the aim of this study was to evaluate the relationships among various lung function parameters to elucidate these issues.<h4>Methods</h4>Demographic data and 26 parameters of full lung function were measured in 94 men with COPD and analyzed using factor and correlation analyses.<h4>Results</h4>Factor analysis revealed five latent factors. Inspiratory capacity (IC)/TLC and residual volume (RV)/TLC were most strongly correlated with all other lung volumes. IC/TLC, RV/TLC, and functional residual capacity (FRC)/TLC were collinear and were potential markers of air trapping, whereas TLC%, FRC%, and RV% were collinear and were potential markers of hyperinflation. RV/TLC >0.4 (or IC/TLC <0.4) was comparable with the ratio of forced expiratory volume in one second (FEV<sub>1</sub>) and FVC <0.7. FVC% and FEV<sub>1</sub>% were poorly correlated with TLC%. The correlation study showed that TLC%, RV/TLC, and FEV<sub>1</sub>% could be used to represent individual latent factors for hyperinflation, air trapping, inspiration, expiration, and obstruction. Combined with diffusion capacity%, these four factors could be used to represent comprehensive lung function.<h4>Conclusions</h4>This study identified collinear relationships among individual lung function variables and thus selecting variables with close relationships for correlation studies should be performed with caution. This study also differentiated variables for air trapping and lung hyperinflation. Lung volume measurements are still required even when spirometry data are available. Four out of 26 lung function variables from individual latent factors could be used to concisely represent lung function.
| S-EPMC6777488 | BioStudies
Project description:The aim of this study was to examine whether electrical impedance tomography (EIT) could determine the presence of ventilation inhomogeneity in patients with chronic obstructive lung disease (COPD) from measurements carried out not only during conventional forced full expiration maneuvers but also from forced inspiration maneuvers and quiet tidal breathing and whether the inhomogeneity levels were comparable among the phases and higher than in healthy subjects. EIT data were acquired in 52 patients with exacerbated COPD (11 women, 41 men, 68 ± 11 years) and 14 healthy subjects (6 women, 8 men, 38 ± 8 years). Regional lung function parameters of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV<sub>1</sub>), forced inspiratory vital capacity (FIVC), forced inspiratory volume in 1 s (FIV<sub>1</sub>), and tidal volume (V <sub><i>T</i></sub> ) were determined in 912 image pixels. The spatial inhomogeneity of the pixel parameters was characterized by the coefficients of variation (CV) and the global inhomogeneity (GI) index. CV and GI values of pixel FVC, FEV<sub>1</sub>, FIVC, FIV<sub>1</sub>, and V<sub>T</sub> were significantly higher in patients than in healthy subjects (<i>p</i> ≤ 0.0001). The ventilation distribution was affected by the analyzed lung function parameter in patients (CV: <i>p</i> = 0.0024, GI: <i>p</i> = 0.006) but not in healthy subjects. Receiver operating characteristic curves showed that CV and GI discriminated patients from healthy subjects with an area under the curve (AUC) of 0.835 and 0.852 (FVC), 0.845 and 0.867 (FEV<sub>1</sub>), 0.903 and 0.903 (FIVC), 0.891 and 0.882 (FIV<sub>1</sub>), and 0.821 and 0.843 (V<sub>T</sub>), respectively. These findings confirm the ability of EIT to identify increased ventilation inhomogeneity in patients with COPD.
| S-EPMC8712108 | BioStudies
Project description:<h4>Background</h4>Circulating markers of oxidative stress have been associated with lower lung function. Our objective was to study the association of gene expression levels of oxidative stress pathway genes (ALOX12, ALOX15, ARG2, GSTT1, LPO, MPO, NDUFB3, PLA2G7, and SOD3) and lung function forced expiratory volume in one second (FEV<sub>1</sub> ), forced vital capacity (FVC) in Coronary Artery Risk Development in Young Adults study.<h4>Methods</h4>Lung function was measured using spirometry and the Nanostring platform was used to estimate gene expression levels. Linear regression models were used to study association of lung function measured at year 30, 10-year decline in lung function and gene expression after adjustment for center, smoking, and BMI, measured at year 25.<h4>Results</h4>The 10-year decline of FEV<sub>1</sub> was faster in highest NDUFB3 quartile compared to the lowest (difference = -2.09%; p = 0.001) after adjustment for multiple comparisons. The 10-year decline in FEV<sub>1</sub> and FVC was nominally slower in highest versus lowest quartile of PLA2G7 (difference = 1.14%; p = 0.02, and difference = 1.06%; p = 0.005, respectively). The other genes in the study were not associated with FEV<sub>1</sub> or FVC.<h4>Conclusion</h4>Higher gene expression levels in oxidative stress pathway genes are associated with faster 10-year FEV<sub>1</sub> decline.
| S-EPMC8683624 | BioStudies
Project description:<h4>Introduction</h4>Airway obstruction is usually assessed by measuring forced expiratory volume in 1 s (FEV<sub>1</sub>), forced vital capacity (FVC) and peak expiratory flow (PEF). This post hoc study investigated comparative responses of lung function measurements in adults and adolescents (full analysis set, N = 3873) following treatment with tiotropium Respimat<sup>®</sup>.<h4>Methods</h4>Lung function outcomes were analysed from five phase III trials in adults (≥ 18 years) with symptomatic severe, moderate and mild asthma (PrimoTinA-asthma<sup>®</sup>, MezzoTinA-asthma<sup>®</sup> and GraziaTinA-asthma<sup>®</sup>, respectively), and one phase III trial in adolescents (12-17 years) with symptomatic moderate asthma (RubaTinA-asthma<sup>®</sup>). Changes from baseline versus placebo in FEV<sub>1</sub>, FVC, PEF and FEV<sub>1</sub>/FVC ratio with tiotropium 5 µg or 2.5 µg added to at least stable inhaled corticosteroids at week 24 (week 12 in GraziaTinA-asthma) were analysed.<h4>Results</h4>All lung function measures improved in all studies with tiotropium 5 µg (mean change from baseline versus placebo), including peak FEV<sub>1</sub> (110-185 mL), peak FVC (57-95 mL) and morning PEF (15.8-25.6 L/min). Changes in adolescents were smaller than those in adults, and were statistically significant primarily for FEV<sub>1</sub> and PEF, but not for FVC.<h4>Conclusion</h4>Consistent improvements were seen across all lung function measures with the addition of tiotropium to other asthma treatments in adults across all severities, whereas the improvements with tiotropium in adolescents primarily impacted measures of flow rather than lung volume. This may reflect less pronounced airway remodelling and air trapping in adolescents with asthma versus adults.
| S-EPMC7229088 | BioStudies
Project description:<h4>Objective</h4>To improve counseling on congenital lung malformations (CLM) by describing long-term outcomes of children either operated on or managed by observation.<h4>Study design</h4>We analyzed lung function (spirometry), exercise tolerance (Bruce treadmill), and physical growth of 8-year-old children with CLM who participated in our longitudinal prospective follow-up program. The data are shown as median standard deviation scores (SDS) with IQR, or estimated marginal means (95% CI) on the basis of general linear models.<h4>Results</h4>Twenty-nine (48%) of the 61 children had required surgery at a median age of 108 (IQR: 8-828) days, and 32 (52%) were managed by observation. In the surgery group, all lung function measurements (except for forced vital capacity [FVC]) were significantly below 0 SDS, with median FEV<sub>1</sub> -1.07 (IQR: -1.70 to -0.56), FEV<sub>1</sub> /FVC -1.49 (-2.62 to -0.33), and FEF<sub>25%-75%</sub> -1.95 (-2.57 to -0.63) (all P < 0.001). Children in the observation group had normal FEV<sub>1</sub> and FVC, whereas FEV<sub>1</sub> /FVC (-0.8<sub>1</sub> (-1.65 to -0.14)) and FEF<sub>25%-75%</sub> (-1.14 (-1.71 to -0.22)) were significantly below 0 SDS (both P < 0.001). Mean exercise tolerance was significantly below 0 SDS in both groups (observation: -0.85 (95% CI: -1.30 to -0.41); surgery: -1.25 (-1.69 to -0.80)); eight (28%) children in the observation group and ten (40%) in the surgery group scored <-1 SDS. Physical growth was normal in both groups.<h4>Conclusion</h4>Children with CLM may be at risk for reduced lung function and exercise tolerance, especially those who required surgery. As little pulmonary morbidity was found in children with asymptomatic CLM, this study supports a watchful waiting approach in this group.
| S-EPMC6766950 | BioStudies
Project description:<h4>Rationale</h4>Rescue/recovery work at the World Trade Center disaster site (WTC) caused a proximate decline in lung function in Fire Department of the City of New York firefighters. A subset of this cohort experienced an accelerated rate of lung function decline over 15 years of post-September 11, 2001 (9/11) follow-up.<h4>Objectives</h4>To determine if early postexposure blood leukocyte concentrations are biomarkers for subsequent FEV<sub>1</sub> decline and incident airflow limitation.<h4>Methods</h4>Individual rates of forced expiratory volume in 1 second (FEV<sub>1</sub>) change were calculated for 9,434 firefighters using 88,709 spirometric measurements taken between September 11, 2001, and September 10, 2016. We categorized FEV<sub>1</sub> change rates into three trajectories: accelerated FEV<sub>1</sub> decline (FEV<sub>1</sub> loss >64 ml/yr), expected FEV<sub>1</sub> decline (FEV<sub>1</sub> loss between 0 and 64 ml/yr), and improved FEV<sub>1</sub> (positive rate of change >0 ml/yr). Occurrence of FEV<sub>1</sub>/FVC less than 0.70 after 9/11 defined incident airflow limitation. Using regression models, we assessed associations of post-9/11 blood eosinophil and neutrophil concentrations with subsequent FEV<sub>1</sub> decline and airflow limitation, adjusted for age, race, smoking, height, WTC exposure level, weight change, and baseline lung function.<h4>Results</h4>Accelerated FEV<sub>1</sub> decline occurred in 12.7% of participants (1,199 of 9,434), whereas post-9/11 FEV<sub>1</sub> improvement occurred in 8.3% (780 of 9,434). Higher blood eosinophil and neutrophil concentrations were each associated with accelerated FEV<sub>1</sub> decline after adjustment for covariates (odds ratio [OR], 1.10 per 100 eosinophils/μl; 95% confidence interval [CI], 1.05-1.15; and OR, 1.10 per 1,000 neutrophils/μl; 95% CI, 1.05-1.15, respectively). Multivariable-adjusted linear regression models showed that a higher blood neutrophil concentration was associated with a faster rate of FEV<sub>1</sub> decline (1.14 ml/yr decline per 1,000 neutrophils/μl; 95% CI, 0.69-1.60 ml/yr; P < 0.001). Higher blood eosinophil concentrations were associated with a faster rate of FEV<sub>1</sub> decline in ever-smokers (1.46 ml/yr decline per 100 eosinophils/μl; 95% CI, 0.65-2.26 ml/yr; P < 0.001) but not in never-smokers (P for interaction = 0.004). Higher eosinophil concentrations were also associated with incident airflow limitation (adjusted hazard ratio, 1.10 per 100 eosinophils/μl; 95% CI, 1.04-1.15). Compared with the expected FEV<sub>1</sub> decline group, individuals experiencing accelerated FEV<sub>1</sub> decline were more likely to have incident airflow limitation (adjusted OR, 4.12; 95% CI, 3.30-5.14).<h4>Conclusions</h4>Higher post-9/11 blood neutrophil and eosinophil concentrations were associated with subsequent accelerated FEV<sub>1</sub> decline in WTC-exposed firefighters. Both higher blood eosinophil concentrations and accelerated FEV<sub>1</sub> decline were associated with incident airflow limitation in WTC-exposed firefighters.
| S-EPMC5802620 | BioStudies
Project description:<h4>Objective</h4>Type 2 diabetes mellitus (DM) has been associated with lung dysfunction, but this association has not been explored in Hispanics/Latinos. The relation between diabetic nephropathy and lung function and symptoms has not been explored.<h4>Research design and methods</h4>The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a large, multicenter, observational study, recruited 16,415 participants aged 18-74 years (14,455 with complete data on variables of interest), between 2008 and 2011 from four U.S. communities through a two-stage area household probability design. Baseline measurements were used for analyses. Forced expiratory volume in 1 s (FEV<sub>1</sub>), forced vital capacity (FVC), and dyspnea score were compared between individuals with and without DM, overall, and stratified by albuminuria. The analyses were performed separately for those with and without preexisting lung disease (chronic bronchitis, emphysema, asthma). Linear regression with sampling weights was used for all analyses.<h4>Results</h4>Among Hispanics/Latinos without lung disease, those with DM had lower mean FEV<sub>1</sub> and FVC values and a higher mean dyspnea score than those without DM (mean [95% CI] FEV<sub>1</sub> 3.00 [2.96-3.04] vs. 3.10 [3.09-3.11] L, P < 0.01; FVC 3.62 [3.59-3.66] vs. 3.81 [3.79-3.83] L, P < 0.001; dyspnea score 0.60 [0.49-0.71] vs. 0.41 [0.34-0.49], P < 0.001). Hispanics/Latinos with DM and macroalbuminuria showed 10% lower FVC (P < 0.001), 6% lower FEV<sub>1</sub> (P < 0.001), and 2.5-fold higher dyspnea score (P = 0.04) than those without DM and with normoalbuminuria. Similar findings but with higher impairment in FVC were found in Hispanics/Latinos with lung disease.<h4>Conclusions</h4>Hispanics/Latinos with DM have functional and symptomatic pulmonary impairment that mirror kidney microangiopathy. The progression of pulmonary impairment in adults with DM needs to be investigated further.
| S-EPMC5079610 | BioStudies
Project description:<h4>Background</h4>A subset of children with asthma respond better to leukotriene receptor antagonists than to inhaled corticosteroids. Information is needed to identify children with these preferential responses.<h4>Objective</h4>We sought to determine whether the ratio of urinary leukotriene E(4) (LTE(4)) to fractional exhaled nitric oxide (FE(NO)) delineates children with preferential responsiveness to montelukast compared with fluticasone propionate (FP) therapy.<h4>Methods</h4>Data from 318 children with mild-to-moderate asthma enrolled in 2 National Heart, Lung, and Blood Institute Childhood Asthma Research and Education Network studies (Characterizing the Response to a Leukotriene Receptor Antagonist and an Inhaled Corticosteroid [CLIC] and the Pediatric Asthma Controller Trial [PACT]) were analyzed. The association between LTE(4)/FE(NO) ratios at baseline and improved lung function or asthma control days (ACDs) with montelukast and FP therapy was determined, and phenotypic characteristics related to high ratios were assessed.<h4>Results</h4>LTE(4)/FE(NO) ratios were associated with a greater response to montelukast than FP therapy for FEV(1) measurements (2.1% increase per doubling of ratio, P = .001) and for ACDs per week (0.3-ACD increase, P = .009) in the CLIC study. In PACT the ratio was associated with greater ACD responsiveness to MT than FP therapy (0.6 ACD increase, P=.03) [corrected]. In a combined study analysis, LTE(4): FE(NO) ratios were associated with greater response to MT than FP therapy for FEV(1) (1.8% increase, P =.0005) and ACDs (0.4 increase, P =.001)[corrected].Children with LTE(4)/FE(NO) ratios at or above the 75th percentile were likely (P < .05) to be younger and female and exhibit lower levels of atopic markers and methacholine reactivity.<h4>Conclusion</h4>LTE(4)/FE(NO) ratios predict a better response to montelukast than FP therapy in children with mild-to-moderate asthma.
| S-EPMC2935914 | BioStudies